Peregrine Ventures Announces New Investor Consortium Including Bristol Myers Squibb, Becton Dickinson and Company, and Elbit Systems Read More
Restore Medical secured a strategic investment of €2.5M from the European Innovation Council Read More
Cordio Mecidal has completed a successful strategic Series C funding round raising a total of $18M Read More
Ribon Therapeutics to present at the 2022 American Association for Cancer Research annual meeting Read More
